Last reviewed · How we verify
FCYC+Conventional treatment
FCYC combined with conventional treatment appears to be a traditional Chinese medicine-based regimen designed to enhance therapeutic outcomes through synergistic effects.
At a glance
| Generic name | FCYC+Conventional treatment |
|---|---|
| Sponsor | Qinhuangdao Hospital of Traditional Chinese Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
FCYC is a formulation from traditional Chinese medicine used adjunctively with standard conventional treatments. The exact molecular mechanisms are not well-characterized in Western pharmacological literature, as the drug originates from a traditional Chinese medicine hospital and likely contains multiple herbal components with complex, multi-target effects rather than a single defined mechanism.
Approved indications
Common side effects
Key clinical trials
- Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: